These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 33251565)
1. What does it mean to develop an HIV vaccine by rational design? van Regenmortel MHV Arch Virol; 2021 Jan; 166(1):27-33. PubMed ID: 33251565 [TBL] [Abstract][Full Text] [Related]
2. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques. Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847 [TBL] [Abstract][Full Text] [Related]
3. Proteins mimicking epitope of HIV-1 virus neutralizing antibody induce virus-neutralizing sera in mice. Kosztyu P; Kuchar M; Cerny J; Barkocziova L; Maly M; Petrokova H; Czernekova L; Liskova V; Raskova Kafkova L; Knotigova P; Masek J; Turanek J; Maly P; Raska M EBioMedicine; 2019 Sep; 47():247-256. PubMed ID: 31544770 [TBL] [Abstract][Full Text] [Related]
4. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan. Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265 [TBL] [Abstract][Full Text] [Related]
5. Challenges for structure-based HIV vaccine design. Schief WR; Ban YE; Stamatatos L Curr Opin HIV AIDS; 2009 Sep; 4(5):431-40. PubMed ID: 20048708 [TBL] [Abstract][Full Text] [Related]
6. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop. Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999 [TBL] [Abstract][Full Text] [Related]
7. HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure. Kwong PD; Mascola JR Immunity; 2018 May; 48(5):855-871. PubMed ID: 29768174 [TBL] [Abstract][Full Text] [Related]
8. Membrane bound Indian clade C HIV-1 envelope antigen induces antibodies to diverse and conserved epitopes upon DNA prime/protein boost in rabbits. Rangasamy SP; Menon V; Dhopeshwarkar P; Pal R; Vaniambadi KS; Mahalingam S Vaccine; 2016 May; 34(21):2444-2452. PubMed ID: 27032514 [TBL] [Abstract][Full Text] [Related]
9. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques. Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585 [TBL] [Abstract][Full Text] [Related]
10. What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure? Alexander MR; Ringe R; Sanders RW; Voss JE; Moore JP; Klasse PJ J Virol; 2015 Jun; 89(11):5981-95. PubMed ID: 25810537 [TBL] [Abstract][Full Text] [Related]
11. Variable epitope libraries: new vaccine immunogens capable of inducing broad human immunodeficiency virus type 1-neutralizing antibody response. Charles-Niño C; Pedroza-Roldan C; Viveros M; Gevorkian G; Manoutcharian K Vaccine; 2011 Jul; 29(32):5313-21. PubMed ID: 21600948 [TBL] [Abstract][Full Text] [Related]
12. Role of neutralizing antibodies in protective immunity against HIV. Srivastava IK; Ulmer JB; Barnett SW Hum Vaccin; 2005; 1(2):45-60. PubMed ID: 17038830 [TBL] [Abstract][Full Text] [Related]
13. Immune systems rather than antigenic epitopes elicit and produce protective antibodies against HIV. Van Regenmortel MHV Vaccine; 2017 Apr; 35(16):1985-1986. PubMed ID: 28320589 [No Abstract] [Full Text] [Related]
14. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response. Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234 [TBL] [Abstract][Full Text] [Related]
15. Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers Ozorowski G; Cupo A; Golabek M; LoPiccolo M; Ketas TA; Cavallary M; Cottrell CA; Klasse PJ; Ward AB; Moore JP J Virol; 2018 Jul; 92(13):. PubMed ID: 29669838 [TBL] [Abstract][Full Text] [Related]
16. Prospects of HIV Env modification as an approach to HIV vaccine design. Hu SL; Stamatatos L Curr HIV Res; 2007 Nov; 5(6):507-13. PubMed ID: 18045108 [TBL] [Abstract][Full Text] [Related]
17. Epitope-Independent Purification of Native-Like Envelope Trimers from Diverse HIV-1 Isolates. Verkerke HP; Williams JA; Guttman M; Simonich CA; Liang Y; Filipavicius M; Hu SL; Overbaugh J; Lee KK J Virol; 2016 Oct; 90(20):9471-82. PubMed ID: 27512064 [TBL] [Abstract][Full Text] [Related]
18. Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope. Correia BE; Ban YE; Holmes MA; Xu H; Ellingson K; Kraft Z; Carrico C; Boni E; Sather DN; Zenobia C; Burke KY; Bradley-Hewitt T; Bruhn-Johannsen JF; Kalyuzhniy O; Baker D; Strong RK; Stamatatos L; Schief WR Structure; 2010 Sep; 18(9):1116-26. PubMed ID: 20826338 [TBL] [Abstract][Full Text] [Related]
19. Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits. Jiang X; Totrov M; Li W; Sampson JM; Williams C; Lu H; Wu X; Lu S; Wang S; Zolla-Pazner S; Kong XP J Virol; 2016 Dec; 90(24):11007-11019. PubMed ID: 27707920 [TBL] [Abstract][Full Text] [Related]
20. Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design. Jardine JG; Sok D; Julien JP; Briney B; Sarkar A; Liang CH; Scherer EA; Henry Dunand CJ; Adachi Y; Diwanji D; Hsueh J; Jones M; Kalyuzhniy O; Kubitz M; Spencer S; Pauthner M; Saye-Francisco KL; Sesterhenn F; Wilson PC; Galloway DM; Stanfield RL; Wilson IA; Burton DR; Schief WR PLoS Pathog; 2016 Aug; 12(8):e1005815. PubMed ID: 27560183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]